Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002081

10% owner bought 300,000 shares at $21.00 ($6,300,000)

  • 10% owner acquired 7,613,887 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-12 Conversion : show line 1 in the form +1,136,525 1,136,525 D
2021-01-12 Conversion : show line 2 in the form +3,551,640 4,688,165 D
2021-01-12 Conversion : show line 3 in the form +2,276,692 6,964,857 D
2021-01-12 Conversion : show line 4 in the form +649,030 7,613,887 D
2021-01-12 Purchase : show line 5 in the form +300,000 $21.00 $6,300,000 7,913,887 D
Open-market purchases · 300,000 sh · avg $21.00 · $6,300,000

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-01-12 Conversion : show line 6 in the form Series Seed Convertible Preferred Stock −1,136,525 0 D
2021-01-12 Conversion : show line 7 in the form Series A Convertible Preferred Stock −3,551,640 0 D
2021-01-12 Conversion : show line 8 in the form Series B Convertible Preferred Stock −2,276,692 0 D
2021-01-12 Conversion : show line 9 in the form Series C Convertible Preferred Stock −649,030 0 D
Loading xslF345X03/doc4.xml…